IE
SVA

Israel Englander’s Sinovac Biotech, Ltd SVA Stock Holding History

Israel Englander’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,195
Closed -$76K – 4580
2018
Q2 		$76K Buy
+10,195
New +$80.2K ﹤0.01% 3678
2017
Q4 		– Sell
-58,083
Closed -$409K – 4353
2017
Q3 		$409K Sell
58,083
-7,364
-11% -$50.3K ﹤0.01% 2933
2017
Q2 		$442K Buy
65,447
+9,595
+17% +$52.6K ﹤0.01% 2867
2017
Q1 		$320K Buy
+55,852
New +$323K ﹤0.01% 3018
2016
Q1 		– Sell
-14,400
Closed -$82K – 4044
2015
Q4 		$82K Sell
14,400
-14,100
-49% -$75.9K ﹤0.01% 3266
2015
Q3 		$145K Buy
+28,500
New +$151K ﹤0.01% 3204
2015
Q1 		– Sell
-31,700
Closed -$166K – 4593
2014
Q4 		$166K Sell
31,700
-9,708
-23% -$49.5K ﹤0.01% 3686
2014
Q3 		$199K Sell
41,408
-42,526
-51% -$228K ﹤0.01% 3439
2014
Q2 		$473K Sell
83,934
-23,019
-22% -$140K ﹤0.01% 2620
2014
Q1 		$770K Buy
+106,953
New +$708K ﹤0.01% 2381
2013
Q4 		– Sell
-29,539
Closed -$177K – 4177
2013
Q3 		$177K Buy
29,539
+1,541
+6% +$7.37K ﹤0.01% 3134
2013
Q2 		$110K Buy
+27,998
New +$104K ﹤0.01% 2860

Other funds holding SVA

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SSP
Sapphire Star Partners Redmond, Washington $74.7M AUM 5.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return

Israel Englander's SVA Position: Q3 2018 in Review

Israel Englander sold out of Sinovac Biotech, Ltd (SVA) in Q3 2018, closing a stake of 10,195 shares — an estimated $76K sold.

Israel Englander first reported a position in SVA in Q2 2013 and held it in 12 quarters. The position peaked at $770K in Q1 2014. 28 funds tracked by Wall St. Rank hold SVA as of Q3 2018.

  • Israel Englander reported no remaining Sinovac Biotech, Ltd position as of Q3 2018 after selling out during the quarter.
  • Israel Englander sold 10,195 Sinovac Biotech, Ltd shares in Q3 2018, an estimated $76K.
  • Israel Englander first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 12 quarters.
  • Israel Englander's Sinovac Biotech, Ltd position peaked at $770K in Q1 2014.
  • 28 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q3 2018.

Based on Millennium Management's 13F filing for Q3 2018, filed 14 Nov 2018.